Sanda MG - Search Results

1

Antitumor efficacy of tumor-antigen-encoding recombinant poxvirus immunization in Dunning rat prostate cancer: implications for clinical genetic vaccine development.

Charles LG, Xie YC, Restifo NP, Roessler B, Sanda MG. Charles LG, et al. Among authors: sanda mg. World J Urol. 2000 Apr;18(2):136-42. doi: 10.1007/s003450050186. World J Urol. 2000. PMID: 10854149 Free PMC article.

2

Molecular characterization of defective antigen processing in human prostate cancer.

Sanda MG, Restifo NP, Walsh JC, Kawakami Y, Nelson WG, Pardoll DM, Simons JW. Sanda MG, et al. J Natl Cancer Inst. 1995 Feb 15;87(4):280-5. doi: 10.1093/jnci/87.4.280. J Natl Cancer Inst. 1995. PMID: 7707419 Free PMC article.

3

Clinical and biological characteristics of familial benign prostatic hyperplasia.

Sanda MG, Doehring CB, Binkowitz B, Beaty TH, Partin AW, Hale E, Stoner E, Walsh PC. Sanda MG, et al. J Urol. 1997 Mar;157(3):876-9. J Urol. 1997. PMID: 9072590

4

Longitudinal cohort analysis of lethal prostate cancer progression in transgenic mice.

Hsu CX, Ross BD, Chrisp CE, Derrow SZ, Charles LG, Pienta KJ, Greenberg NM, Zeng Z, Sanda MG. Hsu CX, et al. Among authors: sanda mg. J Urol. 1998 Oct;160(4):1500-5. J Urol. 1998. PMID: 9751403

5

Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen.

Xie YC, Hwang C, Overwijk W, Zeng Z, Eng MH, Mulé JJ, Imperiale MJ, Restifo NP, Sanda MG. Xie YC, et al. Among authors: sanda mg. J Natl Cancer Inst. 1999 Jan 20;91(2):169-75. doi: 10.1093/jnci/91.2.169. J Natl Cancer Inst. 1999. PMID: 9923859 Free PMC article.

6

Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer.

Sanda MG, Smith DC, Charles LG, Hwang C, Pienta KJ, Schlom J, Milenic D, Panicali D, Montie JE. Sanda MG, et al. Urology. 1999 Feb;53(2):260-6. doi: 10.1016/s0090-4295(98)00539-1. Urology. 1999. PMID: 9933036

7

Early castration reduces prostatic carcinogenesis in transgenic mice.

Eng MH, Charles LG, Ross BD, Chrisp CE, Pienta KJ, Greenberg NM, Hsu CX, Sanda MG. Eng MH, et al. Among authors: sanda mg. Urology. 1999 Dec;54(6):1112-9. doi: 10.1016/s0090-4295(99)00297-6. Urology. 1999. PMID: 10604719

8

Bladder neck-sparing modification of radical prostatectomy adversely affects surgical margins in pathologic T3a prostate cancer.

Marcovich R, Wojno KJ, Wei JT, Rubin MA, Montie JE, Sanda MG. Marcovich R, et al. Among authors: sanda mg. Urology. 2000 Jun;55(6):904-8. doi: 10.1016/s0090-4295(00)00451-9. Urology. 2000. PMID: 10840106

9

Benign prostatic glands at surgical margins of radical prostatectomy specimens: frequency and associated risk factors.

Shah R, Bassily N, Wei J, Mucci NR, Montie JE, Sanda MG, Rubin MA. Shah R, et al. Among authors: sanda mg. Urology. 2000 Nov 1;56(5):721-5. doi: 10.1016/s0090-4295(00)00775-5. Urology. 2000. PMID: 11068287

10

Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.

Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Wei JT, et al. Among authors: sanda mg. Urology. 2000 Dec 20;56(6):899-905. doi: 10.1016/s0090-4295(00)00858-x. Urology. 2000. PMID: 11113727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters